Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 3 Trial

Recent news which mentions Phase 3 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
Novartis' Lung Cancer Candidate Misses Primary Goal In Post Surgery Setting
Tickers NVS
Tags Biotech Large Cap Briefs
From Benzinga
BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program
Tickers BLU
Tags Small Cap Biotech Health Care
From Benzinga
Pfizer's Ulcerative Colitis Candidate Shows Remission In Over 30% Of Patients In Pivotal Studies
Tickers PFE
Tags Large Cap Biotech News
From Benzinga
Novartis - BeiGene's Tislelizumab Aces Late-Stage Esophageal Cancer Trial
Tickers BGNE NVS
Tags NVS Movers News
From Benzinga
Ampio Pharma Shares Fall As FDA Rejects Proposed Change In Knee Osteoarthritis Trial
Tickers AMPE
Tags Biotech After/Hours Center Health Care
From Benzinga
BeiGene Shares Updated Data From Tislelizumab Combo Trial In Head & Neck Cancer
Tickers BGNE
Tags Market News BGNE Benzinga
From Benzinga
Aeglea Bio Stock Gains On Additional Pegzilarginase Data For Rare Metabolic Disease
Tickers AGLE
Tags Market News AGLE Penny Stocks
From Benzinga
Bristol Myers' Neoadjuvant Opdivo/Chemo Improves Event-Free Survival In Early-Stage Lung Cancer Patients
Tickers BMY
Tags General Phase 3 Trial Briefs
From Benzinga
Eli Lilly Reveals More Phase 3 Data From Lebrikizumab Trial In Atopic Dermatitis
Tickers LLY
Tags Market News LLY Benzinga
From Benzinga
Veru's Stock Nearly Triples As COVID-19 Drugs Cuts Reduces Deaths By 55% In Hospitalized Patients
Tickers VERU
Tags Market News Benzinga Trading Ideas
From Benzinga
Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients
Tickers TNXP
Tags Movers Briefs News
From Benzinga
Vaxxinity Receives $9.25M Funding From CEPI To Support Pivotal COVID-19 Vaccine Trial
Tickers VAXX
Tags Briefs News General
From Benzinga
Biophytis Shares Fall As It Stops Enrollment In Sarconeos COVID-19 Trial, Data Expected In Q3 2022
Tickers BPTS
Tags Briefs News Movers
From Benzinga
Citius Pharma Reveals Topline Immunotherapy Data From Late-Stage Lymphoma Trial
Tickers CTXR
Tags Benzinga Trading Ideas Penny Stocks
From Benzinga
AstraZeneca's Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular Disease
Tickers AZN AZNCF
Tags Movers News Briefs
From Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
Tickers NVS
Tags NVS Biotech News
From Benzinga
Theravance Biopharma's Ampreloxetine Shows Benefit In Atrophy Patients, But Not In Parkinson's
Tickers TBPH
Tags Trading Ideas TBPH Benzinga
From Benzinga
Argenx's Vyvgart Long-Term Treatment Shows Improved gMG Disease Scores
Tickers ARGX
Tags Biotech News Briefs
From Benzinga
Lexicon Touts New Favorable Data On Sotaglifozin Cardio Data
Tickers LXRX
Tags Penny Stocks Benzinga Market News
From Benzinga
Merck - Ridgeback's COVID-19 Antiviral Shows Rapid Elimination Of Infectious SARS-CoV-2 Than Placebo
Tickers MRK
Tags Phase 3 Trial COVID/19 Coronavirus Health Care
From Benzinga
Sorrento To Start Late-Stage Trial Of Abivertinib In Critically-Ill COVID-19 Patients
Tickers SRNE
Tags COVID/19 Coronavirus General Phase 3 Trial
From Benzinga
InflaRx Shares Plunge After Disappointing Results On Vilobelimab In Critically Ill COVID-19 Patients
Tickers IFRX
Tags Phase 3 Trial COVID/19 Coronavirus General
From Benzinga
Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial
Tickers RHHBF RHHBY RHHVF
Tags Market News Benzinga RHHBF
From Benzinga
Incyte-Lilly's Olumiant Continue To Show Improved Scalp, Eyebrows, Eyelash Hair Regrowth At 52 Weeks
Tickers INCY LLY
Tags Market News Benzinga LLY
From Benzinga
Roivant' Dermavant Showcases New Long-Term Durability, Tolerability Data For Plaque Psoriasis Candidate
Tickers ROIV
Tags Benzinga Market News Psoriasis
From Benzinga
Celcuity Plans To Start Pivotal Gedatolisib Trial In Breast Cancer In 1H 2022
Tickers CELC
Tags breast cancer CELC General
From Benzinga
AstraZeneca's Imfinzi Flunks In Late-Stage Advanced Cervical Cancer Study
Tickers AZN AZNCF
Tags Benzinga AZNCF Market News
From Benzinga
Pfizer's Ulcerative Colitis Candidate Aces Late-Stage Study
Tickers PFE
Tags News Briefs Biotech
From Benzinga
ObsEva Unveils Additional Efficacy Results for Linzagolix In Endometriosis-Associated Pain
Tickers OBSV
Tags Phase 3 Trial General OBSV
From Benzinga
Tonix Says Fibromyalgia Candidate Failed To Achieve Statistical Significance Over Placebo
Tickers TNXP
Tags TNXP Phase 3 Trial General
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.